Ultra-hypofractionated radiation therapy for unfavourable intermediate-risk and high-risk prostate cancer is safe and effective: 5-year outcomes of a phase II trial
ISSN: 1464-410X, 1464-4096
Ano de publicación: 2020
Volume: 125
Número: 2
Páxinas: 215-225
Tipo: Artigo